AP2444A - New benzothiazinone derivatives and their use as antibacterial agents - Google Patents

New benzothiazinone derivatives and their use as antibacterial agents

Info

Publication number
AP2444A
AP2444A AP2008004723A AP2008004723A AP2444A AP 2444 A AP2444 A AP 2444A AP 2008004723 A AP2008004723 A AP 2008004723A AP 2008004723 A AP2008004723 A AP 2008004723A AP 2444 A AP2444 A AP 2444A
Authority
AP
ARIPO
Prior art keywords
antibacterial agents
new
benzothiazinone derivatives
derivatives
new benzothiazinone
Prior art date
Application number
AP2008004723A
Other languages
English (en)
Other versions
AP2008004723A0 (en
Inventor
Vadim A Makarov
Stewart T Cole
Ute Mollmann
Original Assignee
Leibniz Inst For Natural Product Res Andinfection Biology Ev Hans Knoll Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leibniz Inst For Natural Product Res Andinfection Biology Ev Hans Knoll Inst filed Critical Leibniz Inst For Natural Product Res Andinfection Biology Ev Hans Knoll Inst
Publication of AP2008004723A0 publication Critical patent/AP2008004723A0/xx
Application granted granted Critical
Publication of AP2444A publication Critical patent/AP2444A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2008004723A 2006-05-24 2006-05-24 New benzothiazinone derivatives and their use as antibacterial agents AP2444A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2006/004942 WO2007134625A1 (fr) 2006-05-24 2006-05-24 Nouveaux dÉrivÉs de la benzothiazinone et leur utilisation en tant qu'agents ANTIBACTÉRIENS

Publications (2)

Publication Number Publication Date
AP2008004723A0 AP2008004723A0 (en) 2008-12-31
AP2444A true AP2444A (en) 2012-08-31

Family

ID=37595033

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004723A AP2444A (en) 2006-05-24 2006-05-24 New benzothiazinone derivatives and their use as antibacterial agents

Country Status (24)

Country Link
US (2) US7863268B2 (fr)
EP (1) EP2029583B1 (fr)
JP (1) JP5068813B2 (fr)
KR (1) KR101314999B1 (fr)
CN (1) CN101472922B (fr)
AP (1) AP2444A (fr)
AT (1) ATE470667T1 (fr)
AU (1) AU2006343832B2 (fr)
BR (1) BRPI0621693B8 (fr)
CA (1) CA2652841C (fr)
CR (1) CR10519A (fr)
CY (1) CY1110769T1 (fr)
DE (1) DE602006014885D1 (fr)
DK (1) DK2029583T3 (fr)
EA (1) EA015910B1 (fr)
ES (1) ES2345902T3 (fr)
IL (1) IL195453A (fr)
MX (1) MX2008014958A (fr)
NZ (1) NZ573833A (fr)
PL (1) PL2029583T3 (fr)
PT (1) PT2029583E (fr)
SI (1) SI2029583T1 (fr)
TN (1) TNSN08474A1 (fr)
WO (1) WO2007134625A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2029583B1 (fr) 2006-05-24 2010-06-09 Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut Nouveaux dérivés de la benzothiazinone et leur utilisation en tant qu'agents antibactériens
EP2020406A1 (fr) * 2007-07-16 2009-02-04 Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut Nouveaux composés antimicrobiens, leur synthèse et utilisation pour le traitement des infections liées aux mammifères
CN101971031A (zh) 2008-02-13 2011-02-09 森迪奈尔Ch有限责任公司 用于治疗结核病的有效的新药物靶标
EP2380886A1 (fr) 2010-04-23 2011-10-26 Vadim A. Makarov Procédé de préparation de 2-aminosubstituted 1,3-benzothiazine-4-ones
CN103221399A (zh) * 2010-11-19 2013-07-24 洛桑联邦理工学院(Epfl) 2-哌嗪-1-基-4h-1,3-苯并噻嗪-4-酮衍生物及其用于治疗哺乳动物感染的用途
EP2468746A1 (fr) 2010-12-23 2012-06-27 The University of Queensland Composés benzothiazinone et leur utilisation comme anti-tuberculeux
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
CN102276598B (zh) * 2011-05-27 2014-11-05 四川大学 苯并噻嗪硫酮衍生物及其制备方法和用途
CN102367239B (zh) * 2011-07-20 2015-10-28 沈阳药科大学 2-芳基-2,3-二氢-4h-1,3-苯并噻嗪-4-酮衍生物及其用途
EP2570413A1 (fr) 2011-09-15 2013-03-20 The University Of Queensland Dérivés de benzothiazinone en tant qu'agents anti-tuberculose
CN103508980B (zh) * 2012-06-14 2016-07-06 四川大学 苯并噻嗪-4-酮衍生物及其制备方法和用途
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
CN104211708B (zh) * 2013-05-29 2018-08-24 中国医学科学院药物研究所 苯并噁嗪酮衍生物及其作为抗菌剂的应用
WO2015038978A1 (fr) 2013-09-13 2015-03-19 Symbolics, Llc Measures d'écoulement latéral utilisant des motifs d'essai bidimensionnel et de lecture de signal témoin
CN105705486B (zh) 2013-11-18 2019-03-01 格里洛工厂股份有限公司 用于自烷烃和发烟硫酸制备烷基磺酸的新型引发剂
DE102014012546A1 (de) * 2014-09-26 2016-03-31 Martin-Luther-Universität Halle-Wittenberg Antimykobakteriell wirksame Substanzen, Verfahren zu ihrer Herstellung und deren Verwendung
EP3072889A1 (fr) 2015-03-23 2016-09-28 Ecole Polytechnique Federale De Lausanne (Epfl) Dà‰rivés de 2-homopipérazine-1-yl-4h-1,3-benzothiazine-4-one et procédé pour la préparation d'hydrochlorures de 2- (homo) pipérazine 1,3-benzothiazine-4-one
CN105622596B (zh) * 2016-02-19 2018-10-30 浙江司太立制药股份有限公司 含有烷氧亚胺基氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法
CN105669664B (zh) * 2016-02-19 2019-05-10 浙江司太立制药股份有限公司 含有碱性氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法
JP7125941B2 (ja) * 2016-09-22 2022-08-25 ライプニッツ－インスティトゥート フュア ナチュルストフ－フォルスチュング ウント インフェクションズバイオロジー エー．フェー． ハンス－ノール インスティトゥート （ハーカーイー） 新しい抗微生物化合物、哺乳動物感染症の治療のためのそれらの使用及び新しい代謝メカニズム
RU2663848C1 (ru) * 2018-03-23 2018-08-10 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) 5-Фтор-2-(4-этоксикарбонилпиперазин-1-ил)-1,3-бензотиазин-4-он, обладающий противотуберкулезной активностью
CN111269197A (zh) * 2020-04-08 2020-06-12 苏州大学 苯并噻嗪酮化合物及其制备方法与作为抗结核药物的应用
CN113121521B (zh) * 2021-03-26 2022-11-04 苏州大学 6-位三氟甲基取代的苯并噻嗪酮衍生物及其制备方法与应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522247A (en) * 1967-11-07 1970-07-28 Pfizer & Co C 2-amino-6,7-disubstituted-4h-1,3-benzothiazine-4-ones as bronchodilators
WO2005092872A1 (fr) * 2004-03-26 2005-10-06 Arpida A/S Inhibiteurs de peptide deformylase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470168A (en) * 1967-03-31 1969-09-30 American Home Prod 2-substituted-4h-1,3-benzothiazin-4-one derivatives
GB8611617D0 (en) 1986-05-13 1986-06-18 Shell Int Research Fungicides
AU3704400A (en) 1999-03-04 2000-09-21 E.I. Du Pont De Nemours And Company Fused bicyclic oxazinone and thiazinone fungicides
EP1312607A1 (fr) 2001-11-17 2003-05-21 MEDAC GmbH Dérivés dithiocarbamiques et leur utilisation comme agents antibactériens
AU2003289176A1 (en) 2002-12-05 2004-07-29 Takeda Pharmaceutical Company Limited 1,3-benzothiazinone derivatives, process for producing the same and use thereof
EP2029583B1 (fr) 2006-05-24 2010-06-09 Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut Nouveaux dérivés de la benzothiazinone et leur utilisation en tant qu'agents antibactériens

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522247A (en) * 1967-11-07 1970-07-28 Pfizer & Co C 2-amino-6,7-disubstituted-4h-1,3-benzothiazine-4-ones as bronchodilators
WO2005092872A1 (fr) * 2004-03-26 2005-10-06 Arpida A/S Inhibiteurs de peptide deformylase

Also Published As

Publication number Publication date
CA2652841C (fr) 2015-01-27
JP2009537576A (ja) 2009-10-29
KR20090029736A (ko) 2009-03-23
SI2029583T1 (sl) 2010-09-30
NZ573833A (en) 2010-10-29
AU2006343832B2 (en) 2011-07-21
BRPI0621693B1 (pt) 2020-11-17
EP2029583A1 (fr) 2009-03-04
PL2029583T3 (pl) 2010-10-29
MX2008014958A (es) 2009-04-15
BRPI0621693B8 (pt) 2021-05-25
DK2029583T3 (da) 2010-09-27
PT2029583E (pt) 2010-08-12
US20090239851A1 (en) 2009-09-24
US20110160193A1 (en) 2011-06-30
KR101314999B1 (ko) 2013-10-04
ATE470667T1 (de) 2010-06-15
EA015910B1 (ru) 2011-12-30
TNSN08474A1 (en) 2010-04-14
JP5068813B2 (ja) 2012-11-07
BRPI0621693A2 (pt) 2011-12-20
IL195453A (en) 2013-01-31
EA200870564A1 (ru) 2009-06-30
CY1110769T1 (el) 2015-06-10
US7863268B2 (en) 2011-01-04
CA2652841A1 (fr) 2007-11-29
CN101472922A (zh) 2009-07-01
AP2008004723A0 (en) 2008-12-31
CR10519A (es) 2009-04-14
CN101472922B (zh) 2012-05-30
ES2345902T3 (es) 2010-10-05
EP2029583B1 (fr) 2010-06-09
WO2007134625A1 (fr) 2007-11-29
DE602006014885D1 (de) 2010-07-22
IL195453A0 (en) 2009-08-03
AU2006343832A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
AP2444A (en) New benzothiazinone derivatives and their use as antibacterial agents
GB0612428D0 (en) Antibacterial agents
TWI561237B (en) Substituted dihydropyrazolones and their use
IL184844A0 (en) ??-cyclodextrin derivatives as antibacterial agents
HK1208000A1 (en) Thioninium compounds and their use
AP2007004264A0 (en) Quinoline derivatives as antibacterial agents
EP2007377A4 (fr) Agents antibactériens
ZA200807809B (en) Substituted chromanol derivatives and their use
GB0611115D0 (en) Compounds and their use
HK1127614A1 (en) Aminothiazole derivatives and their uses as antibacterial agents
ZA200808035B (en) Antibacterial agents
HK1120732A1 (en) Quinoline derivatives as antibacterial agents
AP2483A (en) Quinoline derivatives as antibacterial agents
EP1968569A4 (fr) Dérivés de benzopyranone et leur utilisation comme agents anti-coronaviraux
HK1120734A1 (en) Quinoline derivatives as antibacterial agents
GB0619611D0 (en) Compounds and their use
ZA200810642B (en) New benzothiazinone derivatives and their use as antibacterial agents
HU0600122D0 (en) New compounds and their use
GB0623070D0 (en) Antibacterial agents
GB0603376D0 (en) Compounds and their use
GB0619610D0 (en) Compounds and their use
GB0619609D0 (en) Compounds and their use
GB0616577D0 (en) Compounds and their use
GB0603374D0 (en) Compounds and their use
GB0610888D0 (en) Compounds and their use